10-Q: Forian Inc. Reports Increased Revenue in Q1 2025, Driven by Kyber Acquisition and Organic Growth

Forian Inc. saw a revenue increase in Q1 2025, primarily due to the acquisition of Kyber Data Science and organic growth in its information products.

Summary

• Forian Inc. reported its financial results for the quarter ended March 31, 2025.
• Revenue increased to $7,056,116, up from $4,877,378 in the same period last year.
• This increase is attributed to the acquisition of Kyber Data Science and organic growth in the company's information products.
• The company's operating loss was $(1,394,665), compared to $(1,772,350) in the prior year.
• Net loss was $(1,125,862), slightly better than the $(1,212,615) net loss in Q1 2024.
• Basic and diluted net loss per common share remained at $(0.04).
• Adjusted EBITDA was $(50,778) compared to $104,417 in the same period last year.
• Cash and marketable securities totaled $35,666,432 as of March 31, 2025.
• The company had $6,750,326 in outstanding principal and accrued interest on convertible notes due September 1, 2025.
• The company expects to fund its operations and potential future acquisitions through a combination of cash flow generated from operating activities, available cash and marketable securities, debt financing and/or additional equity issuances.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the company is still operating at a loss, there are improvements in revenue and operating loss, indicating progress. However, the material weaknesses in internal controls are a concern.

Positives

• Revenue increased by $2,178,738 to $7,056,116 in Q1 2025.
• Operating loss decreased from $(1,772,350) to $(1,394,665).
• Net loss decreased from $(1,212,615) to $(1,125,862).
• The company acquired Kyber Data Science LLC, which contributed $1,693,347 in revenue for the quarter.
• The company redeemed $1,000,000 in principal and $87,356 of accrued interest on convertible notes in February 2024, resulting in a gain of $137,356.

Negatives

• The company still reported an operating loss of $(1,394,665) and a net loss of $(1,125,862).
• Adjusted EBITDA decreased from $104,417 to $(50,778).
• Gross profit as a percentage of revenues decreased to 56% compared to 65% for the same period in 2024.
• The company identified material weaknesses in its internal controls over financial reporting.

Risks

• The company is evaluating its rights under a contract with an information vendor that will no longer include certain data within the information products it licenses to the company.
• There is no assurance that alternate sources of comparable data can be obtained, and if so, on terms and conditions substantially equivalent to those under the company's previous agreement.
• The company identified material weaknesses in its internal controls over financial reporting.
• The company has $6,750,326 in outstanding principal and accrued interest on convertible notes due September 1, 2025.

Future Outlook

The company expects to continue to fund its operations and potential future acquisitions through a combination of cash flow generated from operating activities, available cash and marketable securities, debt financing and/or additional equity issuances.

Industry Context

The company operates in the healthcare, life sciences, and financial services industries, providing data management and analytics solutions. The acquisition of Kyber Data Science expands the company's capabilities in the financial services sector. The company faces competition from other data analytics providers and must adapt to changes in data licensing agreements.

Comparison to Industry Standards

• It's difficult to provide a precise comparison to industry standards without knowing the specific sub-segments Forian operates in and the specific metrics used by its direct competitors.
• However, generally, data analytics companies are often compared based on revenue growth, gross margin, and customer acquisition cost.
• Companies like Palantir (PLTR) and Snowflake (SNOW) are often seen as benchmarks in the broader data analytics space, though their business models and target markets may differ significantly from Forian's.
• Palantir, for example, focuses on large government and enterprise clients, while Snowflake provides a cloud-based data warehousing solution.
• A more relevant comparison might be to smaller, specialized data analytics firms that focus on the healthcare or financial services industries.
• Comparing Forian's revenue growth and gross margin to these companies would provide a better sense of its relative performance.
• For example, if Forian's gross margin is significantly lower than the industry average, it may indicate higher costs or pricing pressure.
• Similarly, if its revenue growth is slower than its peers, it may suggest challenges in customer acquisition or market penetration.

Related Party Transactions

• Adam Dublin, the company's Chief Strategy Officer, received payments from a current vendor of the company for runoff commissions.
• The company entered into a customer agreement with an entity controlled by one of its directors providing for products and services over a three-year period for variable consideration with aggregate minimum billings of $1,200,000.

Stakeholder Impact

• Shareholders: The increased revenue and reduced operating loss are positive signs, but the company is still operating at a loss.
• Employees: The company is continuing to invest in marketing and sales by expanding selling and marketing staff.
• Customers: The acquisition of Kyber Data Science expands the company's capabilities and may lead to improved products and services.
• Suppliers: The company is evaluating its rights under a contract with an information vendor, which may impact suppliers.
• Creditors: The company has $6,750,326 in outstanding principal and accrued interest on convertible notes due September 1, 2025.

Next Steps

• The company plans to license data from additional vendors in consideration of the above changes.
• The company is currently assessing and improving the operating effectiveness of these controls to ensure they will operate at an acceptable level of assurance.
• The company intends to continue periodic testing and reporting of the internal controls to ensure continuity of compliance.

Key Dates

Keywords

revenue, Kyber, acquisition, financial performance, information products, EBITDA, convertible notes, internal controls, Forian